|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales, exclusive of depreciation and amortization | |||||
| Selling, general and administrative | |||||
| Depreciation | |||||
| Amortization | |||||
| Research and development, net | |||||
| Interest expense | |||||
| Interest income | |||||
| Business restructuring, net | |||||
| Impairment and other-related charges, net | |||||
| Pension settlement charge | |||||
| Asbestos-related claims reserve adjustment | |||||
| Other charges/(income), net | |||||
| Income before income taxes | |||||
| Income tax expense | |||||
| Income from continuing operations | |||||
| Income/(loss) from discontinued operations, net of tax | |||||
| Net income attributable to the controlling and noncontrolling interests | |||||
| Less: Net income attributable to noncontrolling interests | |||||
| Net income (attributable to PPG) | |||||
| Income from continuing operations, net of tax | |||||
| Earnings per common share | |||||
| Continuing operations (in dollars per share) | |||||
| Discontinued operations (in dollars per share) | |||||
| Net Income (attributable to PPG) (in dollars per share) | |||||
| Earnings per common share - assuming dilution | |||||
| Continuing operations (in dollars per share) | |||||
| Discontinued operations (in dollars per share) | |||||
| Net Income (attributable to PPG) (in dollars per share) | |||||
Loading...